USP 800 The Count Down to Required Compliance

Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health, encompassing oversight for forty-seven hospitals. His practice expertise includes sterile compounding and healthsystem automation. His focus is to automate processes, in a system setting, which allow for a data driven approach to ensure medications are delivered safely, and in a timely manner. 

Nationally, Dr. Hunter serves on the BD Connected Medication Management and SCA Advisory Board’s. In the state of Louisiana, he serves as President-Elect for the LSHP, and as the President of the South-East LSHP local chapter. In this setting, he is an advocate for hospital pharmacist and is striving to increase Louisiana Pharmacist participation in LSHP. 

Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health Discusses USP 800
Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health Discusses USP 800

LEARNING OBJECTIVES:

• Discuss the health effects on hazardous drugs on humans
• Describe the practice standards for handling hazardous drugs in healthcare settings
• Evaluate architectural cleanroom designs before construction
• Select cleanroom products appropriate for cleanroom construction

Latest Videos
View all Videos
Executive Insights
Feb 10, 2025

Michael LaFauci, the CEO of MIDAS Healthcare Solutions, leads a company dedicated to the intelligent disposal and visual accountability of medications. MIDAS aims to ensure proof of final destruction of medications, enhancing safety for both patients and healthcare workers.  With a focus on teamwork and the right talent, MIDAS plans to expand its services across the hospital and retail sectors, ensuring proof throughout the medication chain of custody.

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.

Executive Insights
Jan 28, 2025

Venita Abanaka, the Director of Acute Care and Oncology at Parkland Health in Dallas, Texas, is dedicated to serving the underserved in a nearly thousand-bed hospital system. She is focused on redesigning acute care and clinical pharmacy, with an emphasis on automation and networking with vendors and colleagues. Venita values building the next generation of leaders and promotes a culture of servant leadership within her team. Despite challenges like fluid shortages, she views problems as opportunities and maintains a positive relationship with Health Connect Partners.